Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
Date:11/14/2007

Keflex Product Sales Total $3.1 Million in Quarter; Amoxicillin PULSYS NDA

Review Ongoing - PDUFA Date in January 2008

GERMANTOWN, Md., Nov. 14 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced financial and operational results for the quarter ended September 30, 2007.

MiddleBrook reported third quarter 2007 revenue of $3.1 million, up from revenue of $2.7 million in the second quarter of 2007 and from $2.4 million in the third quarter of 2006. Revenue for the first nine months of 2007 increased to $7.6 million, from revenue of $3.6 million for the first nine months of 2006.

MiddleBrook reported research and development (R&D) expenses in the third quarter of $5.5 million, compared to second quarter 2007 R&D expenses of $5.4 million and third quarter 2006 R&D expenses of $5.7 million. Total expenses for the third quarter of 2007 were $13.2 million, compared to $12.2 million in the second quarter of 2007 and $12.2 million in the third quarter of 2006.

Net loss was $10.1 million for the third quarter, compared to a net loss of $9.5 million in the second quarter of 2007 and a net loss of $9.9 million in the third quarter of 2006. Net loss for the first nine months of 2007 was $33.2 million, compared to a net loss of $28.2 million in the first nine months of the prior year.

Net loss per share applicable to common stockholders during the third quarter of 2007 was ($0.22), compared to a net loss per share of ($0.21) in the prior quarter, and a net loss per share of ($0.33) in the comparable quarter of last year. Net loss per share applicable
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Registration is now open for the 4th Annual ... to be held on Sunday, September 21, 2014. The event ... Meadow in Secaucus, New Jersey. All proceeds from the race ... to restoring a sense of self, restoring the family unit, ... families. , General registration is $30 with special pricing for ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 The Outlier ... with extended exclusive interview content from one of the ... Ingredients of Outliers: Women Game Changers . The title ... Outliers: Woman Game Changer Jenny McClendon . McClendon is ... and was formerly the star of WeTV show, Raising ...
(Date:9/1/2014)... Nevada (PRWEB) September 01, 2014 Beginning ... to over 3,000 medical professionals and 10,000 consumers for ... is a 5-day gathering of the nation’s top medical ... associated diseases or conditions. The week-long event contains more ... evidence-based scientific instruction available in the pain management field. ...
(Date:8/31/2014)... 2014 MYMOBILEUNI (MMU) strategy is ... media marketing tools access to digital, resources, courses, ... utilize all tools to reach and collaborate with ... multiple learning channels. , MMU, today announced the ... authoring tool that applies social networking concepts to ...
(Date:8/31/2014)... (PRWEB) September 01, 2014 GoDaddy, ... companies that provide VPS (Virtual Private Server) hosting, ... server computer into many servers, each of which ... someone’s own dedicated computer. Top10BestSEOHosting.com has recently compared ... these three companies are the best VPS hosting ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3Health News:GoDaddy, IX Web Hosting and Bluehost Are Awarded As Hosting Experts by Top10BestSEOHosting.com 2
... a model to identify the agricultural areas with the greatest ... Lynx pardinus ), which is at risk of extinction. The ... the Natural Park of the Sierra de Cardea y Montoro, ... Doana, where this species lives are the most ...
... , DEL MAR, Calif., Sept. 17 In ... nerve pain said that their pain was one of the top ... that people with diabetic nerve pain recognize the condition,s impact on ... discussed the condition with a healthcare provider, just slightly less than ...
... study finds , THURSDAY, Sept. 17 (HealthDay News) ... could predict which people with "mild cognitive impairment" will ... , According to the Alzheimer,s Association, mild cognitive impairment ... problems with memory, language, or another mental function severe ...
... TONBRIDGE, England, Sept. 17 The Contraceptive Pill has ... by leading figures in the drugs industry. , , ... in a star-studded competition organised to celebrate Chemist+Druggist magazine,s 150th birthday. ... in a live debate, with top industry peers voting overwhelmingly for ...
... Stable Medicare Financing Essential for Continued Quality Gains Evidenced ... WASHINGTON, Sept. 17 The American Health ... characterized the health care finance reform plan released by Senate Finance ... and said the process moving forward to a final bill should ...
... ... board for PerfectServe, a healthcare communications company. , ... Knoxville, TN (PRWEB) September 15, 2009 -- Robert Fanning ... board provides guidance on innovative ways to leverage PerfectServe,s physician-contact network serving physician practices ...
Cached Medicine News:Health News:Proposal to reintroduce Iberian lynx on abandoned agricultural land 2Health News:New Survey of People With Diabetic Nerve Pain Shows the Condition Significantly Impacts Daily Activities Such as Exercise and Sleep Yet Often Goes Untreated 2Health News:New Survey of People With Diabetic Nerve Pain Shows the Condition Significantly Impacts Daily Activities Such as Exercise and Sleep Yet Often Goes Untreated 3Health News:New Survey of People With Diabetic Nerve Pain Shows the Condition Significantly Impacts Daily Activities Such as Exercise and Sleep Yet Often Goes Untreated 4Health News:New Survey of People With Diabetic Nerve Pain Shows the Condition Significantly Impacts Daily Activities Such as Exercise and Sleep Yet Often Goes Untreated 5Health News:Trouble With Daily Activities Could Point to Alzheimer's Risk 2Health News:Trouble With Daily Activities Could Point to Alzheimer's Risk 3Health News:Contraceptive Pill Named the Greatest Pharmacy Invention of the Last 150 Years in Chemist+Druggist Competition 2Health News:Baucus Approach to Financing Health Care Reform Step in Right Direction 2Health News:Robert Fanning Named to PerfectServe Advisory Board 2
(Date:8/29/2014)... , Aug. 29, 2014 The clinical and ... be the difference between a product,s success or failure. ... and stratify KOL targets – and then to coordinate ... of strong relationships upon which successful KOL engagement rests. ... companies have identified internal inconsistencies in their KOL management ...
(Date:8/29/2014)... YORK , Aug. 29, 2014 Pomerantz ... TMS S.A. ("EDAP" or the "Company") (NASDAQ: EDAP ... filed in United States District Court, Southern District of ... 14-cv-6069, is on behalf of a class consisting of ... February 1, 2013 and July 30, 2014, inclusive (the ...
(Date:8/29/2014)... 2014 Medina Medical announced today that Mr. ... the Board of Directors on August 18, 2014. Mr. ... commercialization experience, including over a decade of direct experience ... a Partner of the medical device incubator The Foundry, ... Foundry start-ups. Mr. Engelson previously served as the Chief ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... May 26 New Health Sciences Inc. (NHSi) ... the National Heart, Lung and Blood Institute of the ... blood-storage system. The project aims to develop the ... for transfusion therapy and extends the shelf life of ...
... is lower for aneurysm patients treated with coil embolization ... Scientific Corporation (NYSE: BSX ) today welcomed ... The Lancet Neurology showing patients with a ruptured intracranial ... less likely to die within five years compared to ...
Cached Medicine Technology:Bethesda-Based NHSi Wins $2M Grant for Blood Technology 2Bethesda-Based NHSi Wins $2M Grant for Blood Technology 3Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial 2Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial 3Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: